Oncotarget is an online weekly journal that publishes peer-reviewed research papers on oncology and other fields like pathology, aging, immunology, and physiology. The rapid publication of scientific research ensures wide readership, encouraging researchers to focus on developing therapies that can be of great help to patients. The impact of a given research is maximized through constructive and punctual peer review of the articles by several reviewers. Research that goes beyond oncology has helped in eliminating the boundaries between different specialties of biomedical science. Under the leadership of most prominent scientists like the Mikhail Blagosklonny, oncotarget’s editor-in-chief, writers can submit papers, which are accepted, reviewed and approved for publication. Oncotarget is also available on Dove Press.
Before submitting the research paper, an author has to ensure that the work complies with all requirements. For one to be considered as an author, he/she should have contributed efficiently to the conception and design, data acquisition, analysis and interpretation of data in the research paper. An author must have contributed to the drafting of the article and development of the final copy. Before using any information from third parties, the author must request for their consent. Oncotarget accepts group authorship. In such situations, the group will be considered as the author. All members will be required to sign copyright release forms. The names of the members appear in the byline. In addition, the name of the author who will be responsible for the manuscript’s communication is presented as a corresponding author.
Authors should only submit papers whose information is not under consideration or has been published on other platforms. All submitted manuscripts should be original with all copied texts cited accordingly. Any conflict of interest should be revealed to the board of editors on the title page. When a potential conflict of interest is disclosed, notification concerning such a situation is published alongside the article. Authors are guaranteed of the confidentiality of their manuscripts before publication. Editors and reviewers adhere to ethical guidelines that prohibit them from discussing the content of any manuscript under review. Papers undergo unbiased peer-review process. Notably, the identities of reviewers are not disclosed to authors. Writers are also allowed to select or exclude up to five reviewers during submission. Before publication, the editor-in-chief must approve such papers. Follow Oncotarget journal on Twitter.